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Abstract
Background: The Lrig genes encode a family of transmembrane proteins that have been implicated in tumorigenesis,
psoriasis, neural crest development, and complex tissue morphogenesis. Whether these diverse phenotypes reflect a single
underlying cellular mechanism is not known. However, Lrig proteins contain evolutionarily conserved ectodomains
harboring both leucine-rich repeats and immunoglobulin domains, suggesting an ability to bind to common partners.
Previous studies revealed that Lrig1 binds to and inhibits members of the ErbB family of receptor tyrosine kinases by
inducing receptor internalization and degradation. In addition, other receptor tyrosine kinase binding partners have been
identified for both Lrig1 and Lrig3, leaving open the question of whether defective ErbB signaling is responsible for the
observed mouse phenotypes.
Methodology/Principal Findings: Here, we report that Lrig3, like Lrig1, is able to interact with ErbB receptors in vitro.W e
examined the in vivo significance of these interactions in the inner ear, where Lrig3 controls semicircular canal formation by
determining the timing and extent of Netrin1 expression in the otic vesicle epithelium. We find that ErbB2 and ErbB3 are
present in the early otic epithelium, and that Lrig3 acts cell-autonomously here, as would be predicted if Lrig3 regulates
ErbB2/B3 activity. However, inhibition of ErbB activation in the chick otic vesicle has no detectable effect on Netrin gene
expression or canal morphogenesis.
Conclusions/Significance: Our results suggest that although both Lrig1 and Lrig3 can interact with ErbB receptors in vitro,
modulation of Neuregulin signaling is unlikely to contribute to Lrig3-dependent processes of inner ear morphogenesis.
These results highlight the similar binding properties of Lrig1 and Lrig3 and underscore the need to determine how these
two family members bind to and regulate different receptors to affect diverse aspects of cell behavior in vivo.
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Introduction
The mammalian genome contains an expanded repertoire of
transmembrane proteins that carry both leucine-rich repeats
(LRR) and immunoglobulin (Ig) domains in their extracellular
domains [1]. Within this LRR-Ig superfamily, only the Lrig
subfamily contains both invertebrate and vertebrate orthologs,
represented by Dlig1 (also called Lambik) in flies and Lrig1, Lrig2,
and Lrig3 in vertebrates. Lrig proteins have large extracellular
domains with either sixteen (Lrig1 and Lrig3) or fifteen (Lrig2)
LRRs and three Ig domains (Fig. 1). Based on a distant similarity
to Kekkons, which are the only large family of LRR-Ig proteins in
flies [2,3], Lrig proteins have been studied mostly as putative
regulators of ErbB signaling pathways [4–6]. There are four ErbB
receptors: ErbB1, which binds EGF and is thus better known as
the EGF receptor (EGFR), and ErbB2-4, which bind Neuregulin
(NRG) ligands [7]. Upon activation, ErbB receptors form
homophilic and heterophilic dimers, become phosphorylated,
and go on to induce a myriad of cellular processes, including cell
proliferation, differentiation, and survival in glia, neurons, and
mesoderm and in systems as diverse as the heart, lung, and
mammary gland [8–13].
There is considerable evidence that Lrig1 is a negative regulator
of ErbB signaling. Human Lrig1 is induced by EGF signaling and
antagonizes downstream signaling events by binding the extracel-
lular domain of all four ErbB receptors and by enhancing receptor
ubiquitination and subsequent degradation [4–6]. Lrig1 interacts
with ErbB receptors via its extracellular domain, while degrada-
tion seems to involve the recruitment of the E3 ubiquitin ligase c-
Cbl to a site in the cytoplasmic domain of Lrig1 [5]. Consistent
with its role in ErbB receptor degradation in vitro, Lrig1 is deleted in
several different forms of human cancers, and low expression of
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[14–20]. Whether or not other Lrig family members also bind to
ErbB receptors has not been examined. However, both Lrig2 and
Lrig3 have also been implicated in human cancer [21–23].
Although studies of Lrig mutant phenotypes confirm the
importance of Lrig signaling for normal development, the
observed defects do not point to an obvious common underlying
cellular function. Lrig1 mutant mice suffer from a psoriasis-like skin
disorder of unknown origin [24]. This phenotype correlates with
the presence of Lrig1 in the basal cells of the epidermis and hair
follicles and with the prominent role of EGF in keratinocyte
differentiation and proliferation [25,26]; however, specific changes
in ErbB receptor activation or distribution have not been reported.
Lrig3 mutant mice, on the other hand, exhibit obvious develop-
mental defects that manifest as abnormal morphogenesis of the
inner ear and craniofacial structures [27]. The inner ear defect is
caused by expanded expression of the secreted protein Netrin1, a
known regulator of inner ear development [28]. How the Lrig3
transmembrane molecule ultimately induces changes in gene
expression is not known. Hence, it remains unclear whether the
varying collection of defects observed in Lrig1 and Lrig3 mutant
mice are due to changes in ErbB receptor signaling.
There are several reasons to believe that like Lrig1, Lrig3 could
also regulate ErbB signaling. First, Lrig1 is known to interact with
ErbB family members through its extracellular domain, which is
highly conserved in Lrig3. In addition, the intracellular tail of
Lrig3 contains putative SH2 and SH3 domains that have the
potential to bind to activated ErbB receptors. Second, Lrig1 and
Lrig3 expression overlap extensively during development, suggest-
ing a possible functional overlap [27]. Third, despite this broad
expression, both Lrig1 and Lrig3 mutant mice display relatively
mild phenotypes. Strikingly, the Lrig3 mutant phenotypes occur in
regions where Lrig3 but not Lrig1 is expressed, namely the lateral
canal epithelium of the inner ear and the branchial arches. Thus,
Lrig1 may compensate for Lrig3 to regulate ErbB signaling in
other regions of the animal. Indeed, like Lrig1 and Lrig3, ErbB2-4
are also expressed during cochlear maturation [29,30]. Finally,
ErbB signaling plays a crucial and well-established role in complex
morphogenesis of other organ systems, suggesting a possible role
for the ErbB receptors in canal formation [8,10,31].
Based on the close homology between Lrig1 and Lrig3, their
overlapping expression patterns, and the known importance of
ErbB signaling during development, we hypothesized that Lrig3
modulates the Neuregulin pathway in the inner ear. To test this
idea, we performed experiments that address three basic questions:
1) Can Lrig3 interact with ErbB receptors in vitro? 2) Are ErbB
receptors expressed during inner ear development? and 3) Is ErbB
signaling necessary for canal morphogenesis? Our results indicate
that although Lrig3 can interact with ErbB receptors in vitro,
reduction of Neuregulin signaling in vivo does not cause any
detectable changes in Netrin gene expression or in the structure of
the inner ear. These results add to a growing body of evidence that
Lrig proteins exert their effects through multiple signaling
pathways with diverse roles in development and disease.
Results
Lrig3 Can Bind ErbB Receptors In Vitro
Lrig1 and Lrig3 are closely related proteins, sharing the same
number and arrangement of LRRs and Ig domains in the
ectodomain (Fig. 1). The composition of these domains is also
strongly conserved, with 53% identity between the LRRs and even
higher homology in the Ig domains, which are 72% identical. Lrig2,
on the other hand, has one fewer LRR and is rarely expressed in the
same tissues as either Lrig1 or Lrig3 [27]. Moreover, Lrig2 shares
much less homology in the Ig domains (Fig. 1). We therefore focused
on comparisons of Lrig1 and Lrig3, and asked whether Lrig3 behaves
like Lrig1 with respect to ErbB binding and protein distribution.
First, we testedwhether the homologybetweenLrig1 and Lrig3is
sufficienttomediateinteractionswith ErbBreceptors.A seriesofco-
immunoprecipitations were conducted by expressing EGFR,
ErbB2, or ErbB4 together with epitope-tagged constructs of Lrig1
or Lrig3 in HEK293T cells, and in the absence or presence of the
appropriate ligand. Indeed, like Lrig1, Lrig3-flag co-immunopre-
cipitates with EGFR, ErbB2 and ErbB4 in lysates from transfected
cells (Fig. 2A). ErbB3 was not tested as this family member is kinase-
dead and functions as an obligate heterodimer with ErbB2 [7].
Figure 1. Lrig family protein structures. Alignment of Lrig1, Lrig2,
and Lrig3 shows that Lrig1 and Lrig3 share the same number and
spacing of Leucine Rich Repeats (LRRs, green) and Immunoglobulin
domains (Ig, yellow). In contrast, Lrig2 lacks an N’ terminal LRR (blue)
and has a different kind of Ig repeat, as reflected in the lower degree of
identity with Lrig1. In the intracellular domains, all three family
members share a highly conserved (48% identical) stretch of 48 amino
acids (bracketed). Apart from this motif and some putative SH2 and/or
SH3 domains, the cytoplasmic tails vary widely both in length and
composition. Lrig1 is the only family member with a confirmed ability to
bind c-Cbl. Arrows indicate degrees of identity between the LRR
domain-containing regions and the Ig domain-containing regions. The
amino acid (aa) length of each protein is also indicated. Domain
structure was obtained with SMART protein (http://smart.embl-heidel-
berg.de/) and putative intracellular domains were defined by Scansite
(http://scansite.mit.edu/).
doi:10.1371/journal.pone.0008981.g001
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whether, like Lrig1, Lrig3 has the same subcellular distribution as
ErbB receptors. We focused on ErbB4 because it is the only NRG
receptor that functions as a homodimer. Lrig1-flag, Lrig3-flag, and
ErbB4 constructs were expressed either alone or in combination in
HEK293T cells; protein localization was determined by immu-
nostaining for the flag epitope and/or for ErbB4. Like both ErbB4
and Lrig1 (Fig. 2A), Lrig3 is present on the cell surface and in
intracellular compartments (Fig. 2B). Moreover, both Lrig1 and
Lrig3 co-localize with ErbB4 (Fig. 2C,D) Consistent with the role
of Lrig1 in ErbB receptor internalization [5], Lrig1 and ErbB4 are
present in intracellular vesicles when they are co-expressed
Figure 2. Lrig1 and Lrig3 bind to and co-localize with ErbB receptor tyrosine kinases in vitro. (A) Like Lrig1, Lrig3 can co-
immunoprecipitate with multiple ErbB receptors in HEK293T cells. Lysates were immunoprecipitated with anti-flag antibodies and blotted with anti-
ErbB (top) and anti-flag (bottom) antibodies. Both Lrig1-flag and Lrig3-flag can bind to EGFR (left), ErbB2 (middle), and ErbB4 (right) in the absence
(2) or presence (+) of ligand (EGF or NRG). No ErbB receptors were precipitated in the absence of epitope-tagged Lrig (vector). Western blotting
confirms the presence of each ErbB receptor (ErbB), and epitope-tagged Lrig family member (flag) in total lysates (bottom). Actin was used as a
loading control. (B–D) Flag and ErbB4 immunocytochemistry on HEK293T cells transfected with ErbB4, Lrig1-flag, and/or Lrig3-flag alone (B) or in
combinations (C,D). When expressed on their own, Lrig1, Lrig3 and ErbB4 are detected at the cell surface (B). When either Lrig1 (C) or Lrig3 (D) is
expressed in combination with ErbB4, the proteins co-localize in intracellular compartments (arrowheads in C and D).
doi:10.1371/journal.pone.0008981.g002
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than when they are expressed independently (Fig. 2A). Similarly,
Lrig3 and ErbB4 appear to be enriched in the intracellular pool
compared to the cell surface under these conditions (Fig. 2D);
however, this effect was not as dramatic as for Lrig1. Although
more experiments are needed to elucidate the consequences of
Lrig3-ErbB4 co-expression, these results suggest that Lrig1 and
Lrig3 share an ability to interact with ErbB receptors in vitro.
Does Lrig3 Act Through ErbB Pathways In Vivo?
Although Lrig3 can bind to ErbB receptors through a highly
conserved ectodomain, the cytoplasmic domain of Lrig3 bears
little homology to Lrig1, leaving open the question of how Lrig3
activity might ultimately influence NRG signaling. To gain insight
into this question, we took an in vivo approach to determine
whether the phenotypes observed in Lrig3 mutant mice could be
due to misregulated ErbB signaling. The most salient defect in
Lrig3 mutant mice occurs in the vestibular apparatus of the inner
ear, which normally consists of three semicircular canals oriented
with the three dimensions of space. In the absence of Lrig3, the
lateral semicircular canal is truncated due to increased expression
of Netrin1, which encodes a secreted extracellular matrix molecule
required for canal development [27,28]. A role for ErbB signaling
during canal development has not yet been examined. Therefore,
we sought to determine whether Lrig3 acts through ErbB
pathways to orchestrate canal morphogenesis.
ErbB Receptors Are Expressed in the Otic Vesicle
Epithelium
In order to uncover whether Lrig3 acts through ErbB receptors,
we first asked whether ErbB receptors are present during inner ear
development. The vestibular canals are sculpted from the otic
vesicle, a hollow ball of epithelial cells that is formed by
invagination of ectoderm at the level of the hindbrain. The lateral
canal develops from an epithelial outpocketing of the lateral wall of
the otic vesicle at E12 (Fig. 3A). In situ hybridization for ErbB
receptors in E12 otic vesicles revealed that EGFR cannot be
detected in the inner ear but that ErbB3 is broadly expressed
throughout the epithelium (Fig. 3B,C). In situ probes for other
receptors proved to be unreliable and inconclusive. Therefore, to
test for the presence of other ErbB receptors, we microdissected
otic vesicle epithelia and performed a Western blot analysis with
antibodies to all four ErbB receptors (Fig. 3D). As seen by in situ
hybridization, ErbB3 protein is present in abundance, with only
trace amounts of EGFR. ErbB2 protein is also present at high
levels, consistent with the fact that ErbB2 and ErbB3 nearly always
function as a heterodimer. ErbB4 is not detected. Therefore, we
conclude that ErbB2, which cannot bind ligand, and ErbB3,
which is kinase-dead, act together to receive NRG signals in the
otic epithelium.
Lrig3 Acts within the Otic Vesicle Epithelium to Control
Fusion Plate Formation
In our model, Lrig3 acts cell-autonomously to control ErbB
receptor signaling and hence expression of Netrin1 in the otic
epithelium [27]. In support of this idea, in situ hybridization of
ErbB3 reveals strong expression in the epithelium but not the
surrounding mesenchyme. To determine whether Lrig3 is required
in these ErbB-expressing cells, we generated and analyzed
epithelial-specific knock-outs of Lrig3.
Previously, a conditional Lrig3 allele was generated by flanking
the ATG-bearing exon of Lrig3 with LoxP sites [27]. Null mutant
mice exhibit lateral canal truncations and craniofacial defects,
consistent with the complete loss of Lrig3 messenger RNA
(Fig. 4C,D and data not shown). To specifically delete Lrig3 from
otic epithelium, Lrig3
flox conditional mice were crossed to mice
carrying a Pax2Cre transgene, which induces recombination of a b-
galactosidase reporter gene throughout the epithelium (Fig. 4E)
[32]. Deletion of Lrig3 from canal epithelial cells results in the same
lateral canal truncation evident in hypomorphic and null alleles of
Lrig3 (Fig. 4G). Thus, Lrig3 acts within the otic epithelium to
coordinate canal morphogenesis.
Expression of Dominant-Negative ErbB in the Chick Otic
Vesicle Has No Effect on Canal Morphogenesis
Our results indicate that Lrig3 can bind to ErbB receptors and
that ErbB2/B3 are present in the otic epithelium, where Lrig3 acts
cell autonomously to control canal formation. However, while
Lrig1 is known to inhibit ErbB signaling, whether or not Lrig3 has
the same molecular effects is unclear. If Lrig3 normally inhibits
Figure 3. ErbB2 and ErbB3 are present in the developing mouse otic vesicle.( A) Paintfill of an E12 mouse otic vesicle depicting plane of
section shown in B and C (dashed line). The vestibular apparatus (va) develops dorsally and the cochlea extends ventrally. The lateral canal will
develop from the lateral pouch, which is indicated by an asterisk. (B,C) In situ hybridization of EGFR (B) and ErbB3 (C) on adjacent transverse sections
through an E12 mouse head. The otic epithelium is outlined and annotated as in A. Dorsal is up; lateral is right. EGFR message is not detectable in the
otic vesicle, but is present in other tissues (not shown), confirming that the probe worked. ErbB3 is expressed throughout the otic vesicle epithelium.
(D) Western blot of dissected otic vesicle tissue. ErbB2 and ErbB3 are present in abundance, with low levels of EGFR and no detectable ErbB4.
HEK293T cells transfected with each ErbB receptor and hindbrain tissue served as controls. Only ErbB2 and ErbB3 are expressed in hindbrain at this
stage.
doi:10.1371/journal.pone.0008981.g003
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a loss of Netrin1 expression and hence arrested canal formation, as
occurs in Netrin1 mutant mice. Alternatively, if Lrig3 potentiates
ErbB activity, we would predict canal truncations similar to what
is seen in Lrig3 mutant mice. To distinguish between these
possibilities, we performed an unbiased experiment to ask whether
ErbB signaling is required for any aspect of canal morphogenesis.
Several different ErbB mouse mutants are available and have
been studied extensively [33-38]. However, most mutant mice die
at early embryonic stages due to various defects in cardiac
development and are therefore not useful for the study of inner ear
morphogenesis [39–42]. Therefore, we turned instead to the chick
as a model system for canal morphogenesis. The mouse and
chicken inner ear develop similarly both at the cellular and
molecular level [43,44]. However, the chicken is more accessible
and amenable to manipulations than the mouse. Indeed, the chick
has been used successfully in the past for the study of both FGFs
and BMPs in inner ear morphogenesis [45,46].
First, we confirmed the presence of Lrig3 in the chicken inner
ear by in situ hybridization of embryonic day 5 (E5) embryos,
which is comparable to E12 in mouse. As predicted, Lrig3 is
transcribed in the lateral pouch epithelium of the developing chick
as it is in mice, suggesting a common function in both species
(Fig. 5A,D). Similarly, chicken ErbB2 and ErbB3 are expressed
broadly throughout the otic epithelium as in mice (Fig. 5B,C).
Finally, we confirmed expression of two closely-related Netrin
genes, cNetrin1 and cNetrin2, which overlap extensively in the chick
embryo [47,48]. Notably, there is no mouse ortholog of Netrin2,
but in chicks, Netrin activity appears to reflect contributions from
both Netrin1 and Netrin2. Consistent with this idea, we found that
both cNetrin1 and cNetrin2 are present in the fusion plate
epithelium, with cNetrin1 expressed slightly later and at lower
levels (Fig. 5E) than cNetrin2, which appears to be the major player
in chicken (Fig. 5F). As in mouse, this expression is complementary
to cLrig3, which is downregulated in the presumptive fusion plate
and maintained only in the non-fusing epithelium at E6 (Fig. 5D–
F).
To block ErbB signaling in the chicken otic vesicle, we used a
virus to express a truncated version of the ErbB4 receptor. This
construct blocks all Neuregulin signaling by binding NRG ligands
and preventing them from binding to endogenous ErbB2, ErbB3,
and ErbB4 [49] (Fig. 6A). This same strategy was used to block
ErbB signaling successfully in both mice and chickens [30,50,51].
The DNErbB4-flag construct was cloned into the RCAS vector;
control viruses consisted of an RCAS virus expressing either
alkaline phosphatase or a secreted form of GFP. To confirm that
the RCAS(A)/DNErbB4-flag blocks ErbB signaling effectively,
chicken DF1 cells were transfected with ErbB4 to make them
NRG responsive. The same cells were then infected with
increasing amounts RCAS(A)/DNErbB4-flag. As expected, in-
creasing amounts of the dominant negative construct cause a dose-
dependent reduction in ErbB receptor phosphorylation in
response to NRG (Fig. 6B). Hence, NRG signaling is strongly
blocked in the presence of RCAS(A)/DNErbB4-flag. Having
assessed the efficacy of the virus in blocking ErbB signaling, we
next tested the ability of RCAS(A)/DNErbB4-flag to infect
chicken epithelium in vivo. Both in situ hybridization using a probe
specific to the DNErbB4 construct (Fig. 6E) and ErbB4 immuno-
staining of infected chicken otic vesicles sections (Fig. 6F)
demonstrate that DNErbB4 mRNA and protein are produced in
otic epithelium. Therefore, we conclude that RCAS(A)/
DNErbB4-flag provides a suitable tool for blocking NRG signaling
in vivo.
We next assayed whether inhibition of NRG signaling has any
effect on Netrin transcription or canal morphogenesis. RCAS(A)/
DNErbB4-flag (5.6610
9 iu/ml) or control virus (RCAS(A)/GFP
at 2610
9 iu/ml or RCAS(A)/AP at 5610
8 iu/ml) were injected
into the otic vesicles of E3 chickens, allowed to infect for 72 hours
and then sacrificed to assess the level of infection by immuno-
staining against the 3C2-gag viral coat protein (Fig. 7A,C,E,G).
Since patterns of RCAS infection vary from embryo to embryo
and not all infected cells produce the protein of interest, we also
confirmed expression of DNErbB4. Consistent with the broad
expression of 3C2-gag in the mesenchyme and epithelium,
DNErbB4-flag is widely misexpressed in the lateral pouch
epithelium at E5 (Fig. 7C). However, no change in cNetrin1 is
detected either at E5 (Fig.7B,D) or E6 (data not shown). Similarly,
high levels of cNetrin2 are maintained throughout the fusion plate
at E6 despite abundant expression of DNErbB4-flag throughout
the lateral pouch epithelium (Fig.7F,H) (n=10 DNErbB4 infected
and 7 control infected embryos for cNetrin1 and n=9 DNErbB4
infected and 8 control infected embryos for cNetrin2). To assess
Figure 4. Lrig3 acts within the otic epithelium to regulate canal morphogenesis. (A,B) Lateral (A) and top-down (B) views of a paintfilled
E14 Lrig3
flox/flox inner ear reveal normal formation of all structures, including the posterior (pc) and lateral canals (lc). (C,D) Lateral (C) and top-down
(D) views of a paintfilled E14 Lrig3 null inner ear show a truncation of the lateral canal (arrowhead). (E) X-gal staining of a transverse section through
an E12 Pax2Cre;R26R embryo. bgalactosidase activity is restricted to the otic vesicle epithelium. (F,G) Paintfills of E14 inner ears derived from a
Pax2Cre cross to the Lrig3
flox allele. Pax2Cre;Lrig3
flox/- embryos develop a lateral canal truncation (arrowhead) identical to Lrig3 nulls (D). Thus, loss of
Lrig3 from Pax2-positive cells in the otic epithelium recapitulates the null phenotype.
doi:10.1371/journal.pone.0008981.g004
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result in canal defects independent of changes in Netrin expression,
some injected chickens were allowed to develop until E7, when
canal morphogenesis is complete. However, paintfills reveal no
differences in the shape or size of the canals in RCAS(A)/
DNErbB4-flag infected inner ears (n=10) when compared to
controls (n=8) (Fig. 7I–L). There are other sites of ErbB/Lrig3
Figure 5. Expression of cLrig3, cNetrin1, cNetrin2, cErbB2 and
cErbB3 in chick otic epithelium. (A–F) In situ hybridization of cLrig3
(A,D), cErbB2 (B), cErbB3 (C), cNetrin1 (E), and cNetrin2 (F) on transverse
sections of E5 (A) or E6 (B–F) chicken heads. Dorsal is up; lateral is right.
As in the mouse, chicken Lrig3 is initially present throughout the lateral
pouch at E5 (arrows, A), and then sustained in the non-fusing
epithelium (arrow, D) but not the fusion plate (arrowhead, D) at E6.
Hybridization of adjacent sections confirms that chicken Netrin1
expression is complementary to Lrig3, with transcript detected in the
fusing (arrowhead, E) but not non-fusing epithelium (arrow, E). In
addition, cNetrin2, which does not exist in mice, is robustly expressed
overlapping with cNetrin1 in the fusion plate (arrowhead, F). Both ErbB2
and ErbB3 are transcribed throughout the otic epithelium (B) including
the vertical pouch (vp), lateral pouch (lp) and cochlear duct (cd).
doi:10.1371/journal.pone.0008981.g005
Figure 6. RCAS(A)/DNErbB4-flag produces DNErbB4-flag pro-
tein in vitro and in vivo. (A) Diagrams of ErbB2-4 receptors depicting
their extracellular domains (blueandyellow),intracellular kinasemodules
(red), and tyrosine residues (Y). Four Neuregulin ligands (NRG1-4) bind to
ErbB3 and ErbB4 as shown. Since ErbB2 cannot bind ligand and ErbB3 is
kinase dead, ErbB2 and ErbB3 typically heterodimerize in order to bind
and transduce Neuregulin signals. Dominant negative (DN) ErbB4
consists of the extracellular and transmembrane domains of the human
ErbB4 receptor (bracketed), which binds to all four NRG ligands and
prevents them from interacting with their endogenous receptors.
Therefore, DNErbB4 effectively blocks Neuregulin signaling through all
ErbB receptors. (B) Western blot analysis of lysates of DF1 chicken cells
transiently transfected with ErbB4 and infected with RCAS(A)/DNErbB4-
flag in the presence or absence of NRG, as indicated. Production of ErbB4
was confirmed by probing lysates with antibodies to ErbB4 (third row).
Antibodies against the flag epitope reveal the relative amount of
DNErbB4-flag in cells infected with 5610
5 or 5610
6 infectious units of
RCAS(A)/DNErbB4-flag (second row). NRG stimulation of uninfected cells
induces phosphorylation of ErbB4, as detected by blotting with anti-
phosphotyrosine (P-Y) antibodies (top). This phosphorylation is reduced
in the presence of increased levels of DNErbB4-flag. Actin served as a
loading control for the P-Y blot (bottom). (C–F) Adjacent transverse
sections through E5 chicken otic vesicles infected with RCAS(A)/
DNErbB4-flag 48 hours earlier and processed for DAPI staining (C), anti-
3C2 immunostaining (D), DNErbB4 in situ hybridization (E), or anti-ErbB4
immunostaining (F). The DNErbB4 in situ probe and the anti-ErbB4
antibody are specific to human ErbB4. 3C2-gag immunostaining reveals
broad infection of the otic epithelium, including the lateral pouch
(asterisk). Both DNErbB4 transcript (E) and DNErbB4 protein (F) are
producedhere (asterisks).Insomeareas, viralinfectiondoes notgenerate
detectable amounts of DNErbB4-flag (arrowhead). Therefore, in all
subsequent experiments, the extent of infection was monitored by in
situ hybridization for DNErbB4.
doi:10.1371/journal.pone.0008981.g006
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ErbB signaling could result in other defects of inner ear
development that paintfills cannot reveal. In addition, since our
approach does not remove all ErbB activity, we cannot rule out
that transient and/or low levels of NRG signaling persist and are
sufficient for perfect formation of the inner ear. However, since
DNErbB4 was broadly expressed (i.e. Fig. 7C,G) and was highly
effective in vitro (Fig. 6B), these experiments suggest that
misregulation of NRG signaling is unlikely to explain the Lrig3
canal defects.
Discussion
Although Lrig proteins harbor common protein-protein inter-
action motifs in their extracellular domain, their cytoplasmic
domains are widely divergent and specific molecular functions
have remained elusive. Here, we confirm a general ability for Lrig
proteins to interact with ErbB receptors in vitro. However,
misexpression of dominant negative ErbB4 has no effect on Netrin
expression or the structure of the inner ear, suggesting that
aberrant NRG signaling is not a good explanation for Lrig3-
dependent aspects of canal morphogenesis. These results add to
the mounting evidence that Lrig proteins are not dedicated
regulators of ErbB signaling; rather, they may have multiple
functions. Our findings highlight the incomplete knowledge of Lrig
protein function at present.
Since Lrig proteins have highly conserved extracellular domains
with many protein-protein interaction motifs, a better understand-
ing of the nature and variety of bona fide binding partners will
provide important insights into Lrig function. Although ErbB
proteins were the first binding partners to be identified, Lrig
proteins are also able to interact with other receptor tyrosine
kinases that share no homology with the ErbB ectodomain. For
instance, Lrig1 can also inhibit Met and Ret signaling pathways,
while Lrig3 has been shown to bind to the FGF receptor [52–54].
In addition, our own in vitro studies have shown that in addition to
the ErbB receptors, Lrig3 is also able to bind to a wide variety of
receptors, including the Netrin1 receptors Unc5Ha-c, the
Neurotrophin receptor p75 and the axon guidance receptor
PlexinA1 (data not shown). Our discovery that the Lrig3 mutant
phenotype is apparently unrelated to NRG signaling emphasizes
the need to confirm the relevance of each of these in vitro binding
interactions for specific in vivo functions.
Although Lrig1 and Lrig3 may share the ability to interact with
a wide variety of binding partners in vitro, whether or not this
reflects similar cell biological functions in vivo remains unclear.
Although the extracellular domains of Lrig3 and Lrig1 are highly
conserved, the proteins share very little homology in their
intracellular domains. For example, Lrig3 shows no similarity to
Lrig1 in the portion of the cytoplasmic domain that binds to c-Cbl.
Consistent with this observation, although Lrig3 is able to bind to
ErbB receptors, we noticed that unlike Lrig1, Lrig3 does not
induce a dramatic downregulation of ErbB receptor levels (see
Fig. 2A). Rather, there is a trend towards increased ErbB receptor
levels, suggesting that Lrig3/ErbB interactions may not result in
efficient degradation at all. Thus, Lrig3’s ability to bind ErbB
receptors does not necessarily imply that Lrig3 also induces
ubiquitination of ErbB receptors. Indeed, even Lrig1 exhibits c-
Cbl independent functions, since Lrig1-mediated degradation of
the Met receptor does not involve polyubiquitination [53].
Moreover, Lrig1 inhibits Ret function by preventing recruitment
to lipid rafts, with no effect on internalization [52]. Such examples
highlight the possibility that individual Lrig proteins may have
diverse molecular and cellular functions depending on the context.
To date, investigations of Lrig1 and Lrig3 mutant mouse
phenotypes have confirmed that both molecules are important
for aspects of development, but have done little to clarify their
specific functions [24,27]. Although Lrig1 has been proposed to
act through ErbB in the skin, whereas Lrig3 does not seem to
function through NRG signaling in the inner ear, our results do
not rule out shared functions for Lrig1 and Lrig3 in other tissues.
Indeed, based on the broad and overlapping expression patterns
Figure 7. Broad expression of dominant negative ErbB has no
effect on Netrin gene expression or canal morphogenesis. (A–H)
Transverse sections through E5 (A–D) or E6 (E-H) chick heads infected
with control (A,B,E,F) or DNErbB4 (C,D,G,H) virus. The lateral pouch is
outlined in A. The extent of infection was assayed by 3C2-gag
immunostaining for control virus (A,C) or by in situ hybridization for
DNErbB4 (C,G). Adjacent sections were probed for cNetrin1 (B,D) or
cNetrin2 (F,H). At both E5 and E6, cNetrin1 and cNetrin2 are expressed
normally in the fusion plate epithelium (arrowheads, brackets) despite
abundant expression of DNErbB4 here. (I–L) Lateral (I,K) and top-down
(J,L) views of E7 paintfilled inner ears of control (I,J) and experimental
(K,L) embryos. No change in the size or shape of the overall inner ear
(I,L) or lateral canal (J,L) is evident.
doi:10.1371/journal.pone.0008981.g007
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phenotypes evident in each mouse mutant suggests that Lrig1 and
3 may function together. Our studies provide additional evidence
that Lrig1 and Lrig3 can in fact act through common pathways
that have yet to be defined. For instance, Lrig1 and Lrig3 have
similar binding properties, raising the possibility that Lrig3 could
influence Lrig1’s ability to induce receptor internalization. These
similarities with respect to ErbB signaling in vitro could also reflect
a basic binding property that enables interactions with another
signaling pathway that has yet to be defined. The nature of any
additional defects that arise in Lrig1/Lrig3 double mutant mice is
likely to provide useful insights into this question in the future.
Since ErbB receptors do not seem to be involved in the Lrig3-
Netrin feedback loop, the identity of the RTK hypothesized to be
inhibited by Lrig3 remains unclear. The best candidate is the FGF
receptor, not only because Lrig3 is known to bind to and inhibit
FGF receptor [54], but also because of the known importance of
FGF signaling during canal morphogenesis [45,55–57]. FGF
signaling promotes the formation of the fusion plate and the
proliferation of the periotic mesenchyme [57]. Although FGF
ligands and receptors have been identified in several different
regions of the developing inner ear, uncovering a possible Lrig/
FGFR interaction in the inner ear will be difficult, as multiple
feedback-induced antagonists are present and may mask Lrig
activities.
As well as revealing the need to look beyond ErbB receptors as
biologically relevant binding partners for Lrig3, our studies
provide evidence that NRG signaling is not essential for canal
morphogenesis. This result is unexpected given the early and
broad expression of ErbB2/B3 in the otic epithelium as well as the
prominent role for ErbB activation elsewhere in the embryo. As
with any negative result, it is possible that the absence of a
phenotype is due to the technical limitations of the experiment,
since low level NRG signaling could persist in these conditions.
However, we consider this unlikely for the following reasons. First,
this virus effectively blocks NRG signaling in chicken cells (Fig. 6).
Second, we achieved broad expression of DNErbB4 throughout
the otic epithelium (Fig. 7). Third, since DNErbB4 works by
binding to and sequestering the NRG ligand, NRG signaling will
be reduced not only in DNErbB4 expressing cells, but also in the
surrounding tissue. Fourth, the inner ear is extremely sensitive to
even modest changes in signaling, as evidenced by the presence of
defects in several heterozygous mouse lines [46,58]. Nonetheless,
we did not detect even a subtle change in canal structure or Netrin
expression. Finally, although ErbB2 has been shown to be essential
for normal innervation in the inner ear, no canal defects were
reported [59]. Thus, we favor the interpretation that NRG
signaling is not essential for canal morphogenesis.
Nevertheless, it is possible that NRG signaling is important for
other aspects of ear development that may also involve Lrig1 and/
or Lrig3. Our assays were designed to detect changes in canal
structure and cNetrin1/2 gene expression, and would not have
revealedcellularphenotypesinthesensoryepitheliaorotherregions
of the inner ear. For example, Lrig1 and Lrig3 appear to overlap with
ErbB2-4 in the neonatal cochlea [29,60], where they might fine tune
NRG-induced production of BDNF and subsequent neuronal
survival. Indeed, inhibition of NRG signaling in cochlear support
cells by the same construct used here causes spiral ganglion neuron
degeneration and hearing deficits [30]. Thus, while our results rule
out a role in canal morphogenesis, Lrig-ErbB interactions may
influence other aspects of inner ear development and function. If
these activities are uncovered in future investigations of Lrig3 or
Lrig1;Lrig3 mutant animals, more detailed investigations of Lrig3-
ErbB interactions would be warranted.
A deeper understanding of Lrig protein activities will be critical
for elucidating the relationship between Lrig proteins and cancer.
All three family members have been implicated in a broad range of
cancers, either because the gene is deleted or the protein changes
its localization [14–23]. Given the prominent role for NRG
signaling in cancer, it has been often suggested that the loss of
Lrig1 enhances tumor progression by inducing overactivation of
the ErbB pathway [4,17,18]. However, our results suggest that this
is an oversimplified view of Lrig function. It is possible that many
other receptor tyrosine kinase pathways are also misregulated in
the absence of Lrig1, raising the possibility that ErbB-targeted
drugs might not be appropriate in these cases. Conversely,
activation of Lrig with new drugs may not be a viable option for
slowing tumor development. Through continued dissection of the
signaling properties of this intriguing protein family both in vitro
and in vivo, the full extent of Lrig’s contribution to development
and disease will become clear.
Materials and Methods
Plasmids and HEK Transfections
The human N’flag-Lrig1 construct was a gift from H. Hedman
(Umea University, Umea, Sweden). The ErbB4 and DNErbB4-flag
constructs were kindly provided by G. Corfas (Children’s Hospital,
Boston). Full length cDNA from mouse Lrig3 was cloned into
pcDNA3.1+, and a flag tag was cloned into the unique SmaI site
immediately following the signal sequence; the epitope with flanking
protein sequence is HGAPGMDYKDDDDKGQLLDD. HEK293T
cells were cultured in Dulbecco’s Minimal Essential Medium (DMEM)
(Invitrogen) containing 10% fetal bovine serum and 1% penicillin/
streptomycin. Cells were plated at 60–70% confluency on six-well or
10 cm plates, transfected using FuGene6 (Roche), and harvested
24 hours later. When indicated, cells were starved in DMEM without
serum for 16 hours and treated with 1 nM recombinant human
Neuregulin1-b1 (NRG1, R&D Systems) or 200 ng/ml of Human
EGF (Protech) for 10 min before lysis.
Co-Immunoprecipitation
Cells were washed with cold phosphate buffered saline (PBS) and
lysed in 20 mM Tris (pH 7.4), 150 mM NaCl, 1 mM EDTA,
1 mM EGTA, 1% TritonX-100, 2.5 mM sodium pyrophosphate,
1m Mbglycerolphosphate, 1 mMNa3VO4, and 1 mMofPefabloc
(Roche). For immunoprecipitations, lysates were pre-cleared with
agarose-conjugated normal IgG for 30 min at 4uC and immuno-
precipitated with agarose conjugated flag antibody (M2, Sigma)
overnight at 4uC. Samples were washed four times with lysis buffer
before the beads were resuspended in SDS sample buffer and boiled
for 5 min. Western analysis was performed using standard protocols
and the following antibodies: EGFR (1:1000, Santa Cruz), ErbB2
(1:1000, Abcam), ErbB3 (1:1000, Santa Cruz), ErbB4 (1:1000,
Santa Cruz); flag (1:1000 M2, Sigma), and actin (1:8000, Abcam).
Immunocytochemistry
Cells grown on glass coverslips were fixed with 4% parafor-
maldehyde (PFA) in PBS for 10 min on ice, permeabilized in
0.1%Triton X-100 for 10 min, blocked with 5% bovine serum
albumin (BSA) for 30 min, and then incubated overnight at 4uC
with primary antibodies diluted in blocking solution: flag (1:1000,
M2 Sigma) and ErbB4 (1:500, Santa Cruz). The coverslips were
washed with PBS, and detection was performed using appropriate
secondary antibodies (1:2000, Jackson Immunoresearch) for
1 hour at room temperature. Nuclei were counterstained with
DAPI for 5 min (1:10,000, Sigma), washed with PBS, and
mounted with Vectashield (Vector Laboratories).
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flox conditional mice [27] and Pax2Cre mice [32] have been
maintained for over five generations on C57Bl6/J background.
Rosa26 reporter mice (R26R)[ 6 1 ]a n dZ/EG reporter [62] have been
maintained for over five generations on a CD1 background.
Genotyping was performed as described or using primers to amplify
Cre [297 (ATTTGCCTGCATTACCGGTC) and 298 (ATCAA-
CGTTTTCTTTTCGGA)] or GFP [7110 (TACGGCAAGCTGA-
CCCTGAAGTTC) and 7111 (AAGTCGATGCCCTTCAGCTC-
GATG)]. All mice are maintained in accordance with institutional
and NIH guidelines approved by the IACUC at Harvard Medical
School.
In Situ Hybridization
Non-radioactive in situ hybridization was performed on 12–
14 mm frozen sections using the following probes: Mouse: EGFR
(ENSMUST00000020329, nt3816–4429) and ErbB3 (ENSM-
UST00000020329, nt4230–4800); Chicken: cLrig3 (ENSGA-
LG00000009755, nt2931–3643), cErbB2 (NM_001044661.1,
nt2235–2934), cErbB3 (NM_001044669.1, nt2173–2880), cNetrin2
(L34550, nt2097–2645). The chicken Netrin1 probe was provided
by C. Cepko (Harvard Medical School), and the DNErbB4 probe
was a gift from G. Corfas (Children’s Hospital, Boston). A detailed
protocol is available at http://goodrich.med.harvard.edu/.
Otic Vesicle Western Blots
Pax2Cre;Z/EG otic vesicles were microdissected from E12
embryos and lysed as described above. The samples were
homogenized on ice for 10 min, and then centrifuged at 10006g
for 10 min at 4uC. Supernatant was either used immediately for
Western analysis or frozen in SDS sample buffer at 280uC.
Western analysis was performed as described above using the
following antibodies: EGFR (1:1000, Santa Cruz), ErbB2 (1:1000,
Abcam), ErbB3 (1:1000, Santa Cruz), ErbB4 (1:1000, Santa Cruz).
X-Gal Staining
Staining for b2galactosidase was performed as described [63]
except that 10–20 mm frozen sections were used, and the tissue
was fixed for 1 hour at 4uC.
Construction, Production and Validation of RCAS(A)/
DNErbB4 Virus
A Replication-Competent Avian sarcoma-leukosis retroviral
vector, RCAS(A), containing the DNErbB4-flag construct was
built using Gateway recombination cloning into the RCASBP-Y
DV destination vector [64]. Specifically, attB1 and attB2 sites were
added to the ends of DNerbB4-flag fragment using PCR with
primers B1F_DNEB (59 GGGGACAAGTTTGTACAAAAAAG-
CAGGCTGAACCATGATGAAGCCGGCGACAGGACT 39)
and B2R_DNEB (59 GGGGACCACTTTGTACAAGAAAGC-
TGGGTCTCACTTGTCG-TCATCGTCTTTG 39). The PCR
fragments were first inserted into pDONR221, using BP Clonase
II (Invitrogen), resulting in an entry vector, pME-DNEB. The
DNerbB4-flag fragment in pME-DNEB was cloned into
RCASBP-Y DV using LR Clonase II (Invitrogen) to create
pRCAS-DNErbB4 proviral vector. RCAS/DNErbB4-flag virus
stock was generated in UMNSAH/DF-1 chicken fibroblasts
(ATCC CRL-12203), concentrated by centrifugation and titered
on these cells as described previously [65].
RCAS(A)/DNErbB4-flag was used at a titer of 5.6610
9
infectious units/ml (iu/ml). Control viruses included an
RCAS(A)/GFP at a titer of 2610
9 infectious units/ml and
RCAS(A)/AP at a titer of 5610
8 infectious units/ml. To validate
that RCAS(A)/DNErbB4-flag blocks NRG signaling, DF1 chicken
cells were grown to ,30% confluency and transiently transfected
with ErbB4 using FuGene6 (Invitrogen). The next day, each well
was infected with either no virus, 5.6610
5 iu/ml or 5.6610
6 iu/
ml of virus for an hour while rocking at 37uC. 24 hours post-
infection, cells were serum starved for an additional 16 hours and
then treated with 1 nM recombinant human Neuregulin1-b1
(NRG1, R&D Systems) for 10 minutes before lysis. Western
analysis of the cell lysates was performed with the following
antibodies: phosphotyrosine (1:1000, Upstate), flag (1:1000, M2,
Sigma); ErbB4 (1:1000, C-18, Santa Cruz); and actin (1:8000,
Abcam). Chicken DF1 cells were maintained in DMEM (Invitro-
gen) with 10% FBS, 5% chicken serum, and 1% penicillin/
streptomycin.
Viral Infection of Chick Otic Vesicles
White leghorn premium quality chicken eggs were maintained
in a 39uC humidified incubator for the duration of the
experiment (7 days), according to IACUC guidelines at Harvard
Medical School. RCAS(A)/DNErbB4-flag virus or control virus
was injected into the right otic vesicle of E3 (stage 17) chick
embryos. In order to visualize the amount of virus injected, 1–
5 ml of 0.25% Fast Green solution was combined with 10–50 ml
of virus. Using a backloading pipette tip (Eppendorf), 5 mlo ft h e
virus with the Fast Green solution was loaded into a glass pipette
that had been previously prepared by pulling Omega dot
capillaries (No. 30-30-0 1.0 mm od; 0.75 mm id; 100 mm long;
FHC, Brunswick, ME). To inject the virus, we used a
picospritzer needle holder attached to a micromanipulator
(Picospritzer: Picospritzer III from Parker Ins; micromanipula-
tor: Siskiyou Instruments; stand: Fisso S-20 from Flexbar).
Tungsten needle and forceps were used to open the vitelline
membrane that surrounds the head of the embryo. The loaded
pipette tip was inserted into the otic vesicle using the
micromanipulator, and with the picrospritzer, the virus was
injected to fill the entire otic vesicle. Following a successful
injection the egg was sealed and placed back into the humidified
incubator until E5, E6, or E7.
Immunohistochemistry
E5 chick embryos were collected and fixed for 1–2 hours at 4uC
in 4% PFA/PBS and then dehydrated in 30% sucrose/PBS
overnight at 4uC and equilibrated in Neg50 (Richard-Allan
Scientific) for 2–3 hours at 4uC, followed by embedding in
Neg50. Frozen sections (10–14 mms) were blocked and permea-
bilized in 5% normal donkey serum +2% BSA +0.1% Triton X-
100 in PBS for 1 hour at room temperature. Primary antibodies
were added into the above block, without Triton X-100, overnight
at 4uC at the following concentrations: 3C2-gag protein (1:10,
DSHB) and c-ErbB4 (1:250, H4.77.16 Neomarkers). The
following day, the sections were incubated in Alexa Fluor488 or
Alexa Fluor568 antibody (1:2000, Jackson Immunoresearch) in
block, without Triton X-100. All sections were counterstained with
DAPI (1:10,000).
Paintfills
E7 chick or E14 mouse heads were fixed overnight at 4uC with
Bodian’s Fix, dehydrated overnight at room temperature with
100% ethanol, then cleared overnight at room temperature with
methyl salicylate. Heads were hemisected, and white latex paint
(Benjamin Moore) diluted to 0.025% in methyl salicylate was
injected into the cochlea with a pulled glass pipette and a
Hamilton syringe filled with glycerol.
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